- Home
- NLSP vs AEI Comparison
NLSP vs AEI Comparison
Compare NLSP & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- AEI
- Stock Information
- Founded
- NLSP 2015
- AEI 2014
- Country
- NLSP Switzerland
- AEI United States
- Employees
- NLSP N/A
- AEI N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- AEI Building operators
- Sector
- NLSP Health Care
- AEI Real Estate
- Exchange
- NLSP Nasdaq
- AEI Nasdaq
- Market Cap
- NLSP 12.4M
- AEI 10.9M
- IPO Year
- NLSP 2021
- AEI N/A
- Fundamental
- Price
- NLSP $2.13
- AEI $1.07
- Analyst Decision
- NLSP
- AEI
- Analyst Count
- NLSP 0
- AEI 0
- Target Price
- NLSP N/A
- AEI N/A
- AVG Volume (30 Days)
- NLSP 268.4K
- AEI 120.5K
- Earning Date
- NLSP 07-22-2025
- AEI 08-12-2025
- Dividend Yield
- NLSP N/A
- AEI N/A
- EPS Growth
- NLSP N/A
- AEI N/A
- EPS
- NLSP N/A
- AEI N/A
- Revenue
- NLSP N/A
- AEI $16,097,995.00
- Revenue This Year
- NLSP N/A
- AEI N/A
- Revenue Next Year
- NLSP N/A
- AEI N/A
- P/E Ratio
- NLSP N/A
- AEI N/A
- Revenue Growth
- NLSP N/A
- AEI N/A
- 52 Week Low
- NLSP $1.30
- AEI $0.70
- 52 Week High
- NLSP $15.59
- AEI $2.61
- Technical
- Relative Strength Index (RSI)
- NLSP 43.58
- AEI 55.44
- Support Level
- NLSP $2.20
- AEI $1.05
- Resistance Level
- NLSP $2.33
- AEI $1.15
- Average True Range (ATR)
- NLSP 0.25
- AEI 0.10
- MACD
- NLSP -0.07
- AEI 0.01
- Stochastic Oscillator
- NLSP 6.86
- AEI 38.67
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.